Search research articles
Contact Us
Filters
Showing results (21-30 of 48) with videos related to
Page
of 5
Sort By:
Therapeutic Advances in Neurological Disorders
|
June 18, 2019
Clinical trials in multiple sclerosis: potential future trial designs
Navid Manouchehri, Yinan Zhang, Amber Salter, et al.
Frontiers in Immunology
|
October 14, 2022
Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide
Bart Van Wijmeersch, Hans-Peter Hartung, Patrick Vermersch, et al.
Plos One
|
November 19, 2010
Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis
Sebastian Doerck, Kerstin Göbel, Gesa Weise, et al.
Transplantation and Cellular Therapy
|
January 2, 2026
Proposal for Diagnostic Criteria for Manifestations of Chronic Graft-versus-Host Disease in the CNS
Alexander Denk, Daniel Wolff, Matthias A Fante, et al.
Neurochemistry International
|
August 14, 2010
Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses
Johann Sellner, Sabine Cepok, Sudhakar Reddy Kalluri, et al.
BMC Neurology
|
July 14, 2016
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab
Tjalf Ziemssen, Achim Gass, Jens Wuerfel, et al.
Neuro-Oncology Advances
|
August 22, 2025
MRI-defined patterns of infiltration and outcome in patients with glioblastoma
Katrin Scheu, Edith Vandieken, Katharina Hense, et al.
Neuro-Oncology Advances
|
November 4, 2024
Effect of antibiotic drug use on outcome and therapy-related toxicity in patients with glioblastoma-A retrospective cohort study
Linda Götz, Tananeh Ansafi, Michael Gerken, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
October 13, 2023
Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis
John Kramer, Ralf Linker, David Paling, et al.
Frontiers in Immunology
|
November 3, 2022
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in
Maura Pugliatti, Hans-Peter Hartung, Celia Oreja-Guevara, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 48) with videos related to
Sort By:
Page
of 5
Therapeutic Advances in Neurological Disorders
|
June 18, 2019
Clinical trials in multiple sclerosis: potential future trial designs
Navid Manouchehri, Yinan Zhang, Amber Salter, et al.
Frontiers in Immunology
|
October 14, 2022
Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide
Bart Van Wijmeersch, Hans-Peter Hartung, Patrick Vermersch, et al.
Plos One
|
November 19, 2010
Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis
Sebastian Doerck, Kerstin Göbel, Gesa Weise, et al.
Transplantation and Cellular Therapy
|
January 2, 2026
Proposal for Diagnostic Criteria for Manifestations of Chronic Graft-versus-Host Disease in the CNS
Alexander Denk, Daniel Wolff, Matthias A Fante, et al.
Neurochemistry International
|
August 14, 2010
Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses
Johann Sellner, Sabine Cepok, Sudhakar Reddy Kalluri, et al.
BMC Neurology
|
July 14, 2016
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab
Tjalf Ziemssen, Achim Gass, Jens Wuerfel, et al.
Neuro-Oncology Advances
|
August 22, 2025
MRI-defined patterns of infiltration and outcome in patients with glioblastoma
Katrin Scheu, Edith Vandieken, Katharina Hense, et al.
Neuro-Oncology Advances
|
November 4, 2024
Effect of antibiotic drug use on outcome and therapy-related toxicity in patients with glioblastoma-A retrospective cohort study
Linda Götz, Tananeh Ansafi, Michael Gerken, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
October 13, 2023
Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis
John Kramer, Ralf Linker, David Paling, et al.
Frontiers in Immunology
|
November 3, 2022
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in
Maura Pugliatti, Hans-Peter Hartung, Celia Oreja-Guevara, et al.
Page
of 5